FDA analysis of J&J COVID vaccine booster sets the stage for public hearing

Johnson & Johnson has asked the Food and Drug Administration to authorize a booster for people 18 and older six months after initial immunization, with an option to vaccinate after two months.
http://dlvr.it/S9WR73